Business Segments Outlook Therapeutics, Inc.
Stocks
OTLK
US69012T3059
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.6395 USD | -2.49% |
|
-2.01% | -59.53% |
| 09-20 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to S&P Global BMI Index | CI |
| 08-27 | Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | - | - | - | - | 1.41M | |||||
Total Assets | 22.81M | 28.53M | 32.3M | 28.82M | 18.58M | |||||
Interest Expense | -936K | -1.49M | -1.56M | -3.16M | -283K | |||||
Income Tax Expense | 2K | 2.8K | 2.8K | 2.8K | -1.55M | |||||
CAPEX | - | - | - | - | - | |||||
EBT | -53.16M | -66.05M | -58.98M | -75.36M | -63.98M | |||||
Gross Profit | - | - | - | - | 57.2K | |||||
D&A | 262K | 205K | 44.19K | 114K | 117K | |||||
Operating Income | -51.73M | -63.07M | -53.13M | -71.7M | -67.06M | |||||
Net Income | -53.16M | -66.05M | -58.98M | -75.37M | -62.42M |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | - | - | - | - | 1.41M | |||||
Total Assets | 22.81M | 28.53M | 32.3M | 28.82M | 18.58M | |||||
Interest Expense | -936K | -1.49M | -1.56M | -3.16M | -283K | |||||
Income Tax Expense | 2K | 2.8K | 2.8K | 2.8K | -1.55M | |||||
D&A | 262K | 205K | 44.19K | 114K | 117K | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | 57.2K | |||||
Net Income | -53.16M | -66.05M | -58.98M | -75.37M | -62.42M | |||||
EBT | -53.16M | -66.05M | -58.98M | -75.36M | -63.98M | |||||
Operating Income | -51.73M | -63.07M | -53.13M | -71.7M | -67.06M |
- Stock Market
- Stocks
- OTLK Stock
- Financials Outlook Therapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
